Shefali Miller

1.5k total citations
45 papers, 1.1k citations indexed

About

Shefali Miller is a scholar working on Psychiatry and Mental health, Clinical Psychology and Pharmacology. According to data from OpenAlex, Shefali Miller has authored 45 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Psychiatry and Mental health, 12 papers in Clinical Psychology and 7 papers in Pharmacology. Recurrent topics in Shefali Miller's work include Bipolar Disorder and Treatment (38 papers), Electroconvulsive Therapy Studies (22 papers) and Schizophrenia research and treatment (9 papers). Shefali Miller is often cited by papers focused on Bipolar Disorder and Treatment (38 papers), Electroconvulsive Therapy Studies (22 papers) and Schizophrenia research and treatment (9 papers). Shefali Miller collaborates with scholars based in United States, Italy and South Korea. Shefali Miller's co-authors include Terence A. Ketter, Bernardo Dell’Osso, J B Gould, Po W. Wang, Farnaz Hooshmand, Shelley J. Hill, Jessica N. Holtzman, Trisha Suppes, Kathryn C. Goffin and Anda Gershon and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and Journal of Affective Disorders.

In The Last Decade

Shefali Miller

40 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shefali Miller United States 16 701 228 201 195 170 45 1.1k
Isabella Soreca United States 16 800 1.1× 175 0.8× 96 0.5× 231 1.2× 38 0.2× 29 1.2k
Philipp Ritter Germany 18 755 1.1× 195 0.9× 50 0.2× 164 0.8× 57 0.3× 54 1.2k
John Abel Engh Norway 20 1.3k 1.9× 303 1.3× 55 0.3× 164 0.8× 49 0.3× 35 1.8k
Halldóra Jónsdóttir Norway 19 1.3k 1.8× 304 1.3× 56 0.3× 117 0.6× 53 0.3× 24 1.6k
Paul Mackin United Kingdom 17 637 0.9× 111 0.5× 54 0.3× 151 0.8× 44 0.3× 34 1.1k
Alessandro Miola Italy 16 462 0.7× 205 0.9× 36 0.2× 200 1.0× 50 0.3× 64 925
Danielle M. Novick United States 13 777 1.1× 348 1.5× 73 0.4× 71 0.4× 46 0.3× 27 1.0k
Katherine Tracy United States 15 649 0.9× 286 1.3× 28 0.1× 50 0.3× 216 1.3× 19 1.0k
Mark S. Bauer United States 9 515 0.7× 189 0.8× 34 0.2× 53 0.3× 45 0.3× 12 769
Leonardo Tondo United States 15 828 1.2× 278 1.2× 47 0.2× 102 0.5× 186 1.1× 23 1.4k

Countries citing papers authored by Shefali Miller

Since Specialization
Citations

This map shows the geographic impact of Shefali Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shefali Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shefali Miller more than expected).

Fields of papers citing papers by Shefali Miller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shefali Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shefali Miller. The network helps show where Shefali Miller may publish in the future.

Co-authorship network of co-authors of Shefali Miller

This figure shows the co-authorship network connecting the top 25 collaborators of Shefali Miller. A scholar is included among the top collaborators of Shefali Miller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shefali Miller. Shefali Miller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Miller, Shefali, et al.. (2025). Emotional granularity in health and psychopathology: A scoping review. Journal of Psychiatric Research. 190. 277–295.
2.
3.
Kaufmann, Christopher N., Anda Gershon, Colin A. Depp, et al.. (2018). Daytime midpoint as a digital biomarker for chronotype in bipolar disorder. Journal of Affective Disorders. 241. 586–591. 13 indexed citations
4.
Hooshmand, Farnaz, Anda Gershon, Bernardo Dell’Osso, et al.. (2018). Antidepressants have complex associations with longitudinal depressive burden in bipolar disorder. Journal of Affective Disorders. 246. 836–842. 5 indexed citations
5.
Miller, Shefali, et al.. (2018). Longer-Term Effectiveness and Tolerability of Adjunctive Open Lurasidone in Patients With Bipolar Disorder. Journal of Clinical Psychopharmacology. 38(3). 207–211. 5 indexed citations
6.
Rasgon, Natalie, Hyun Kim, Kathryn C. Goffin, et al.. (2017). Lifetime eating disorder comorbidity associated with delayed depressive recovery in bipolar disorder. International Journal of Bipolar Disorders. 5(1). 25–25. 15 indexed citations
7.
Hooshmand, Farnaz, et al.. (2017). Episode accumulation associated with hastened recurrence and delayed recovery in bipolar disorder. Journal of Affective Disorders. 227. 657–664. 10 indexed citations
8.
Gershon, Anda, et al.. (2017). Abnormal sleep duration associated with hastened depressive recurrence in bipolar disorder. Journal of Affective Disorders. 218. 374–379. 28 indexed citations
9.
Kim, Jane, Hyun Kim, Bernardo Dell’Osso, et al.. (2017). Lifetime anxiety disorder and current anxiety symptoms associated with hastened depressive recurrence in bipolar disorder. Journal of Affective Disorders. 219. 165–171. 12 indexed citations
10.
Miller, Shefali, et al.. (2016). Current irritability associated with hastened depressive recurrence and delayed depressive recovery in bipolar disorder. International Journal of Bipolar Disorders. 4(1). 15–15. 9 indexed citations
11.
Miller, Shefali, Po W. Wang, Farnaz Hooshmand, et al.. (2016). Current irritability robustly related to current and prior anxiety in bipolar disorder. Journal of Psychiatric Research. 79. 101–107. 12 indexed citations
12.
Goffin, Kathryn C., Jessica N. Holtzman, Farnaz Hooshmand, et al.. (2016). Differential prevalence and demographic and clinical correlates of second-generation antipsychotic use in bipolar I versus bipolar II disorder. Journal of Psychiatric Research. 76. 52–58. 5 indexed citations
13.
Ketter, Terence A., Shefali Miller, Bernardo Dell’Osso, & Po W. Wang. (2015). Treatment of bipolar disorder: Review of evidence regarding quetiapine and lithium. Journal of Affective Disorders. 191. 256–273. 33 indexed citations
14.
Holtzman, Jessica N., Shefali Miller, Farnaz Hooshmand, et al.. (2015). Childhood-compared to adolescent-onset bipolar disorder has more statistically significant clinical correlates. Journal of Affective Disorders. 179. 114–120. 42 indexed citations
15.
Ketter, Terence A., Po W. Wang, & Shefali Miller. (2015). Bipolar Therapeutics Update 2014: A Tale of 3 Treatments. The Journal of Clinical Psychiatry. 76(1). 69–70. 5 indexed citations
16.
Dell’Osso, Bernardo, Jessica N. Holtzman, Kathryn C. Goffin, et al.. (2015). American tertiary clinic-referred bipolar II disorder compared to bipolar I disorder: More severe in multiple ways, but less severe in a few other ways. Journal of Affective Disorders. 188. 257–262. 40 indexed citations
17.
Ketter, Terence A., Shefali Miller, Bernardo Dell’Osso, et al.. (2014). Balancing benefits and harms of treatments for acute bipolar depression. Journal of Affective Disorders. 169. S24–S33. 38 indexed citations
18.
Hooshmand, Farnaz, et al.. (2013). Trends in pharmacotherapy in patients referred to a bipolar specialty clinic, 2000–2011. Journal of Affective Disorders. 155. 283–287. 35 indexed citations
19.
Miller, Shefali, Joachim Hallmayer, Po W. Wang, et al.. (2012). Brain-derived neurotrophic factor val66met genotype and early life stress effects upon bipolar course. Journal of Psychiatric Research. 47(2). 252–258. 29 indexed citations
20.
Miller, Shefali, Pichai Ittasakul, Po W. Wang, et al.. (2012). Enhanced Ziprasidone Combination Therapy Effectiveness in Obese Compared to Nonobese Patients With Bipolar Disorder. Journal of Clinical Psychopharmacology. 32(6). 814–819. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Isabella Soreca Breakdown of academic impact, for papers by Philipp Ritter Breakdown of academic impact, for papers by John Abel Engh Breakdown of academic impact, for papers by Halldóra Jónsdóttir Breakdown of academic impact, for papers by Paul Mackin Breakdown of academic impact, for papers by Alessandro Miola Breakdown of academic impact, for papers by Danielle M. Novick Breakdown of academic impact, for papers by Katherine Tracy Breakdown of academic impact, for papers by Mark S. Bauer Breakdown of academic impact, for papers by Leonardo Tondo
Rankless by CCL
2026